« FDA Licenses for Marketing New Therapy for Rare Genetic Disease | Main | FDA Approvals - Spiration, Inc. Receives First FDA Approval for Bronchial Valve (Centre »

FDA Approves Rapaflo for the Treatment of Symptoms Due to


FDA Approves Rapaflo for the Treatment of Symptoms Due to an Enlarged Prostate Gland
The U.S. Food and Drug Administration today approved Rapaflo (silodosin) capsules for the treatment of symptoms due to benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate.
 

©2006 FDA-News.com. All rights reserved.